Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Intracellular calcium release in hepatocytes is primarily mediated by the inositol 1,4,5-trisphosphate receptor (IP3R), a ligand-gated ion channel located on the endoplasmic reticulum membrane. Upon activation by second messenger IP3 (generated via PLC activation after stimulation by extracellular ligands like ATP, vasopressin, glucagon, and epinephrine), IP3R releases Ca^2+ from the ER into the cytosol. This rise in cytoplasmic calcium regulates diverse functions in the liver, such as cellular metabolism, secretion, proliferation, and the response to injury. Increases in intracellular calcium can also be mediated by ryanodine receptors, but in hepatocytes, IP3Rs are dominant. Pharmacological and pathological modulation of this pathway is implicated in liver regeneration, carcinogenesis, and liver injury responses.
Ligand (IP3)-gated channel opening to release calcium from the endoplasmic reticulum (ER); Modulation by signaling pathways (PLC, G-protein coupled receptors/agonists such as ATP, vasopressin, glucagon, epinephrine)
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Inositol 1,4,5-trisphosphate receptor (IP3R).